BioSpace News Archive

The submission is based on positive results from the Phase III POLYP 1 and POLYP 2 studies of Xolair in adults with chronic rhinosinusitis with nasal polyps with inadequate response to intranasal corticosteroids

Mérieux Equity Partners is pleased to announce that the Mérieux Participations 3 fund has entered the capital of Addmedica – a French pharmaceutical laboratory specialized in the development and marketing of high added value medical products.

The 12th Clinical Trials on Alzheimer’s Disease 2019 was held in San Diego, USA, from December 4-7. At the CTAD, the results of various Alzheimer’s disease clinical trials were shared, and it provided a glimpse into the possibility of treating Alzheimer’s disease.

Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTC: HMTXF) is pleased to announce the appointment of David Wood to the position of Chairman, Bryson Goodwin to the position of Chief Executive Officer, Thomas Smeenk to the position of President, and Natasha Sever to the position of Chief Financial Officer.

Glooko®, the global leader in diabetes data management, today announced it has received Privacy Shield certification from the U.S. Department of Commerce

Madrigal Pharmaceuticals, Inc. announced the pricing of the previously-announced underwritten secondary offering by investment funds affiliated with Bay City Capital LLC, of 1,200,000 shares of Madrigal’s common stock at the public offering price of $107.85 per share.

Technavio has announced its latest market research report titled global bilirubin blood test market 2019-2023

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced it has begun an expansion of its Tredegar facility in Wales, UK to enhance its high potent drug manufacturing and development capabilities, including both clinical and commercial supply

Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor microenvironment, today announced the appointment of Lara Sullivan, M.D. as Chief Executive Officer and Director.

The Systems-based Pharmaceutics Alliance welcomes Sanofi S.A. as its newest member.